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In spite of the wealth of clinical evidence supporting the health benefits of Lactobacillus rhamnosus GG in
humans, there is still a lack of understanding of the molecular mechanisms behind its probiosis. Current
knowledge suggests that the health-promoting effects of this probiotic strain might be partly dependent on its
persistence in the intestine and adhesion to mucosal surfaces. Moreover, L. rhamnosus GG contains mucus-
binding pili that might also explain the occupation of its ecological niche as a comparatively less stringent
allochthonous intestine-dwelling bacterium. To uncover additional surface proteins involved in mucosal ad-
hesion, we investigated the adherence properties of the only predicted protein (LGG_02337) in L. rhamnosus
GG that exhibits homology with a known mucus-binding domain. We cloned a recombinant form of the gene
for this putative mucus adhesin and established that the purified protein readily adheres to human intestinal
mucus. We also showed that this mucus adhesin is visibly distributed throughout the cell surface and
participates in the adhesive interaction between L. rhamnosus GG and mucus, although less prominently than
the mucus-binding pili in this strain. Based on primary structural comparisons, we concluded that the current
annotation of the LGG_02337 protein likely does not accurately reflect its predicted properties, and we propose
that this mucus-specific adhesin be called the mucus-binding factor (MBF). Finally, we interpret our results
to mean that L. rhamnosus GG MBF, as an active mucus-specific surface adhesin with a presumed ancillary
involvement in pilus-mediated mucosal adhesion, plays a part in the adherent mechanisms during intestinal
colonization by this probiotic.
The commensal Gram-positive lactobacilli are one of the
first groups of bacteria to inhabit the human gastrointestinal
(GI) tract (16) and include some strains (autochthonous) that
colonize the intestine stably throughout the lifetime of the host
(31). In addition, there are those strains, called allochthonous,
that persist only briefly in the intestine, many of these being
probiotics (1, 9, 13) and understood to stimulate health-bene-
fiting immune responses in host intestinal cells (for a review,
see reference 14) or cause competitive displacement of invad-
ing pathogens (for a review, see reference 35). Thus far, the
precise molecular mechanisms that differentiate the coloniza-
tion ability between autochthonous and allochthonous intesti-
nal lactobacilli remain undefined (42), although they are likely
to be partly dependent on a diverse range of cell surface ad-
hesion molecule-mediated interactions with the host intestinal
mucosa. With that being said, there are a growing number of
reports in the literature that indicate that lactobacillar adher-
ence to the intestinal mucosal layer is mediated by surface
proteins with a mucus-binding capacity (15, 21, 22, 25, 30, 32,
33, 41). Moreover, homology-driven genome mining in several
Lactobacillus spp. (3, 7, 8, 11, 33) has identified the presence of
various-sized putative mucus adhesins consisting of one or
more copies of an approximately 100- to 200-amino-acid (aa)
mucus-binding (MUB) domain repeat, which, given its preva-
lence in lactic acid bacteria (LAB), can be considered a unique
functional feature for promoting host-microbe interplay in the
GI tract (7).
In a recent study, we reported that proteinaceous pilus-like
structures protrude from the cell surface of a widely used
probiotic Lactobacillus strain (21). Earlier studies have primar-
ily characterized Gram-positive pili as virulence factors in
pathogen-mediated disease and illness (for a review, see ref-
erence 37). However, with the discovery that Lactobacillus
rhamnosus GG is a piliated strain (21) and that an intestinal
mucus-binding capacity is associated with the corresponding
pili (called SpaCBA) (21, 41), new light has been shed on the
putative role of piliation as a novel surface-localized feature in
mediating intestinal colonization by probiotic lactobacilli. As a
typical probiotic, L. rhamnosus GG adopts the characteristic
colonization behavior associated with allochthonous bacteria
(42) and so persists only transiently in the GI tract (1). How-
ever, compared to the genetically similar but non-SpaCBA-
piliated L. rhamnosus LC705 strain, piliation might offer a
possible explanation for the heightened ability of L. rhamnosus
GG to adhere to intestinal mucosal surfaces (39) and to occupy
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its intestinal niche with greater duration (21). In this context,
L. rhamnosus GG might be regarded as a more sustainable
allochthonous strain than L. rhamnosus LC705.
Up to now, SpaCBA pilus fibers have been characterized as
the predominant surface-localized component for L. rhamno-
sus GG mucosal adhesion (21, 41). However, there are growing
indications that other LPXTG-anchored cell wall proteins,
such as MabA (29), also function in the adherence of this
probiotic strain to the host intestinal mucosa. As an additional
example, the LGG_02337 open reading frame (ORF), which
includes the primary structural elements for an N-terminal
secretion signal, 4 Pfam-MucBP (mucin-binding protein) do-
main repeats, and a C-terminal sortase-specific LPXTG cell
wall-anchoring domain (21), represents the only predicted sur-
face protein in L. rhamnosus GG that exhibits amino acid
identity to a recognized mucus-binding domain (4). Interest-
ingly, a homologous form of this LPXTG-like surface protein
(encoded by the LC705_02328 ORF) is found in the less-
mucus-adherent L. rhamnosus LC705 strain (39) and, like in L.
rhamnosus GG, is the only predicted protein that contains
acknowledged mucus-related adhesion domains (21). Typi-
cally, the Pfam-MucBP domain repeats are shorter in length
(50 aa) than the predicted MUB domains present in the
large-sized Mub (mucus-binding) proteins produced by various
Lactobacillus spp. (7). However, besides being the canonical
component of mucus-binding proteins in other LAB, the Pfam-
MucBP domain repeat is also a characteristic element of nu-
merous proteins in different Listeria spp. (7). For instance, the
Pfam-MucBP domain can be found frequently in the internalin
(Inl) family of leucine-rich repeat-containing surface proteins
that are exclusive to the food-borne pathogen Listeria mono-
cytogenes (6). Ostensibly due to the shared sequence similarity
with the Pfam-MucBP domain repeats found typically in the
Inl-like proteins, the ORFs for LGG_02337 in L. rhamnosus
GG and LC705_02328 in L. rhamnosus LC705 have been an-
notated previously as internalins (21).
We now present a study performed to determine the con-
tributing role of the LGG_02337-encoded LPXTG-like protein
in promoting L. rhamnosus GG adhesion to the intestinal mu-
cosa. The characterization of this putative adhesin involved
analyzing its primary structure, assessing its adherence to hu-
man intestinal mucus, and demonstrating its cell surface local-
ization and in vivo functionality. Based on our results reported
herein, we propose that this LPXTG-like protein be renamed
and referred to as the mucus-binding factor (MBF).
MATERIALS AND METHODS
Bacterial strains, plasmids, and DNA manipulations. Escherichia coli strains
TOP10 [F mcrA (mrr-hsdRMS-mcrBC) 80lacZM15 lacX74 recA1
araD139 (ara-leu)7697 galU galK rpsL (Strr) endA1 nupG] and BL21(DE3)/
pLysS [F ompT hsdSB(rB mB) gal dcm (DE3) pLysS (Camr)] were used for
plasmid preparation and protein expression, respectively. E. coli was routinely
grown in Luria-Bertani (LB) medium at 37°C with agitation and was supple-
mented with 50 g/ml kanamycin when required. The pET28b expression
vector (Novagen) was used for the cloning and production of recombinant L.
rhamnosus GG MBF protein. Lactobacillus rhamnosus GG (ATCC 53103) and
L. rhamnosus LC705 (DSM 7061) strains (both kind gifts from Valio Ltd.,
Finland) were used for antibody-mediated mucus-binding inhibition experi-
ments. Genomic DNA from L. rhamnosus GG was generously provided by Lars
Paulin (University of Helsinki, Helsinki, Finland) and was isolated using the
procedure described previously (21). Standard DNA protocols were used for
molecular cloning and related procedures as described previously (36).
E. coli cloning of the LGG_02337 ORF. The coding sequence of the L. rham-
nosus GG LGG_02337 ORF (21) lacking the DNA region for N-terminal secre-
tion and C-terminal LPXTG-like recognition signals was PCR amplified from
genomic DNA using a forward oligoprimer containing an EcoRI restriction site
(5-TAGTCACGTGAATTCGAGCTCGGTGG [EcoRI site is italicized]) and a
reverse oligoprimer containing an XhoI restriction site (5-CTTTTCGTTCTCG
AGAGGCAGCCGCCGCTG [XhoI site is italicized]) (Oligomer, Finland). Am-
plified DNA, cleaved by EcoRI and XhoI restriction endonucleases, was ligated
into the pET28b expression vector, which was then transformed into chemically
competent E. coli TOP10 cells. The resulting plasmid construct (pKTH5323) was
subsequently transformed into the E. coli BL21(DE3)/pLysS expression strain for
the production of cytosolic C-terminal hexahistidine-tagged MBF protein. The
recombinant form of MBF also includes seven residues at the N terminus and
two residues preceding the hexahistidine sequence at the C terminus that orig-
inated from amino acids encoded by the expression vector.
Production and purification of recombinant MBF protein. Recombinant MBF
protein production and purification was performed using the procedure essen-
tially as described previously (21, 41). Briefly, E. coli cells harboring the
pKTH5323 plasmid were grown until mid-log phase at 37°C in kanamycin-
supplemented (50 g/ml) LB medium, and MBF protein production was then
induced for 3 h by 1 mM isopropyl -D-1-thiogalactopyranoside (IPTG). After
the cells were harvested by centrifugation, the cell pellet was resuspended in lysis
buffer (50 mM NaH2PO4 [pH 8.0], 300 mM NaCl, 10 mM imidazole] and
subjected to sonic oscillation in order to disrupt the cells. The lysed cell suspen-
sion was centrifuged to remove cellular debris and unbroken cells and was then
membrane filtered (0.45-m pore size) to produce a clarified cell-free protein
extract. Immobilized nickel affinity chromatography was used to purify hexahis-
tidine-tagged MBF protein. The cell-free protein extract was loaded onto a
nickel nitrilotriacetic acid (Ni-NTA) agarose (Qiagen) column and rinsed with
several bed volumes of wash buffer (50 mM NaH2PO4 [pH 8.0], 300 mM NaCl,
20 mM imidazole), and the recombinant MBF protein was then eluted from the
column with elution buffer (50 mM NaH2PO4 [pH 8.0], 300 mM NaCl, 250 mM
imidazole). Elution fractions judged to contain purified MBF were pooled, buffer
was exchanged with 10 mM Tris-HCl (pH 8.0) by using an EconoPac 10 DG
desalting column (Bio-Rad), and protein was concentrated using a 30-kDa Mi-
crosep filter (Pall Life Sciences). Protein purity was visualized by SDS-PAGE,
and the protein concentration was estimated by A280 measurements. Recombi-
nant L. rhamnosus GG SpaC pilin protein served as a control and was produced
and purified according to a method described previously (21).
L. rhamnosus GG MBF antiserum preparation. Antiserum specific for L.
rhamnosus GG MBF protein was produced using the method described previ-
ously (21, 41). In brief, rabbits were first injected subcutaneously with a 1-ml
volume of 400 g purified recombinant MBF protein and Freund’s complete
adjuvant (1:1 mixture), and then 1-ml subcutaneous booster injections of 200 g
MBF protein in Freund’s incomplete adjuvant (1:1 mixture) were administered
at 3-week intervals over a 9-week period. Blood was collected 14 days after the
last booster injection, and the antiserum was prepared as described previously
(19).
Construction of L. rhamnosus GG CMPG5351 mutant strain. The L. rham-
nosus GG knockout derivative strain, an inactivated exopolysaccharide (EPS)
welE (CMPG5351; welE::Tcr) mutant, was used for demonstrating MBF cell
surface localization by electron microscopic means. Details about its construction
have been described previously (23).
Radiolabeling of recombinant MBF protein and L. rhamnosus cells. Purified
MBF protein was radiolabeled with 125I as described previously (21, 41) using
Pierce iodination reagent according to the manufacturer’s instructions (Pierce).
Radiolabeled MBF protein was chromatographically separated from residual
unbound radiolabel using a D-Salt polyacrylamide desalting column (Pierce).
For use as controls in mucus-binding experiments, recombinant SpaC pilin (pos-
itive control) and ovalbumin (Sigma) (background control) were radiolabeled
using the aforementioned procedure as described previously (21, 41). The L.
rhamnosus GG and LC705 strains were metabolically radiolabeled with tritiated
thymidine using the procedure described previously (40). Briefly, L. rhamnosus
cells were grown overnight in MRS liquid medium containing 10 l/ml [5-
3H]thymidine (16.7 Ci/nmol) and were then harvested by centrifugation. After
two washes in phosphate-buffered saline (PBS) (pH 7.2), the cell pellet was
resuspended in the same buffer, and the number of cells was normalized by
adjusting the optical density at 600 nm (OD600) to 0.25.
Isolation of mucus from the human intestine. The source of human intestinal
mucus, established previously for use in binding experiments (28), was surgically
removed tissue that was provided by patients diagnosed with an operable stage
of colorectal cancer and undergoing colonic resection. The ethics committee for
the Hospital District of Southwest Finland authorized the isolation and use of
4466 VON OSSOWSKI ET AL. APPL. ENVIRON. MICROBIOL.
the resected human intestinal tissue in this study. In addition, participating
patients were fully informed beforehand and had provided their written consent.
Noncancerous tissue segments containing intact mucosa were selected, and the
mucus gel layer was recovered as described previously (40).
Binding of radiolabeled recombinant MBF to intestinal mucus. Binding ex-
periments between radiolabeled recombinant MBF protein and human intestinal
mucus was carried out using the procedure described previously (21, 41). Briefly,
Maxisorp microtiter plate wells (Nunc) containing saturating amounts of intes-
tinal mucus were incubated overnight at 4°C, rinsed several times with PBS to
remove unbound mucus, and then incubated in a blocking solution of 0.5%
bovine serum albumin (BSA) in PBS for 1 h at room temperature. After the
blocking solution was aspirated away, 50 pmol of radiolabeled MBF protein
dissolved in blocking solution was added to wells containing immobilized mucus
and incubated at 37°C for 1 h. Wells were rinsed three times with PBS, and then
the amount of protein-bound 125I was assessed using a Wallac 1480 Wizard
3-inch automatic gamma counter (PerkinElmer). In addition, binding between
intestinal mucus and 50 pmol radiolabeled SpaC pilin (positive control) and
ovalbumin (background control) was determined.
Antibody-mediated inhibition of L. rhamnosus GG adhesion to intestinal mu-
cus. The adhesion of L. rhamnosus GG cells to intestinal mucus was inhibited by
anti-MBF serum using the procedure described previously (21, 41). Briefly,
3H-labeled wild-type (WT) L. rhamnosus GG cells were first preincubated with
anti-SpaC pilin serum (diluted 1:100) and then treated either with or without
anti-MBF serum (diluted 1:100). Antibody-untreated WT L. rhamnosus GG
served as a positive adhesion control. As an additional control, radiolabeled cells
of the L. rhamnosus LC705 strain were treated with or without anti-MBF serum
(diluted 1:100). Aliquots (100 l) of the antiserum-cell suspension were then
added to intestinal mucus-coated microtiter plate wells (40) and incubated at
37°C for 1 h. After the wells were rinsed twice with PBS to remove loosely
mucus-adhering cells, cells still remaining attached to bound mucus were incu-
bated in lysis solution (1% SDS-0.1 N NaOH) at 60°C for 1 h. The amount of
radioactivity in the lysed cell suspensions was then determined by liquid scintil-
lation counting. Adhesion to mucus was expressed as a percentage calculated
from the ratio between the amounts of radioactivity measured for the lysed cell
suspension and the cell suspension added originally to the wells.
L. rhamnosus cell fractionation and recovery of cell wall proteins. Cell frac-
tionation and extraction of cell wall-bound proteins from WT L. rhamnosus GG,
its EPS (welE) (CMPG5351) knockout mutant derivative, and WT L. rhamnosus
LC705 were carried out as described previously (21), with some modifications. In
brief, after each of the L. rhamnosus strains were grown overnight, a 1-ml volume
of their cells (OD600 of 4.0) was centrifuged, and the pelleted cells were then
rinsed once with PBS. Cells were then lysed mechanically three times for 120 s
by glass bead disruption (Bu¨hler Vibrogen-Zellmu¨hle) and, after a 0.5-ml volume
of PBS was added, low-speed centrifugation (1,000 	 g for 1 min) was used to
remove the unbroken cells and cellular debris from the disrupted cell suspension.
The clarified cell lysate was then fractionated by centrifugation at 16,000 	 g for
30 min at 4°C to separate cytosolic and cell wall-associated components. After
the removal of the cell-free cytosolic supernatant fraction, cell wall proteins were
recovered by resuspension of the pellet fraction in 50 l of digestion buffer (50
mM Tris-HCl [pH 8.0], 5 mM MgCl2, 5 mM CaCl2, 10 mg/ml lysozyme, and 150
U/ml mutanolysin) and then incubation at 37°C for 3 h.
Immunoblotting detection of MBF protein in L. rhamnosus cell wall extracts.
Cell wall-associated proteins recovered from WT L. rhamnosus GG, its EPS
knockout mutant strain (CMPG5351), and WT L. rhamnosus LC705 were ana-
lyzed by SDS-PAGE followed by immunoblotting essentially as described previ-
ously (21). All samples were electrophoresed under denaturing conditions on 4
to 15% gradient gels (Bio-Rad) and then electroblotted onto polyvinylidene
difluoride (PVDF) Immobilon P membranes (Millipore). Membranes were
treated with anti-MBF serum diluted 1:10,000 and then incubated with goat
anti-rabbit IgG horseradish peroxidase (HRP)-conjugated secondary antibody
(Bio-Rad) diluted 1:100,000. MBF protein was visualized by enhanced chemilu-
minescence using the Amersham ECL Advance Western blotting detection kit
(GE Healthcare Bio-Sciences, Uppsala, Sweden) according to the protocol rec-
ommended by the manufacturer.
Electron microscopy and immunogold labeling of L. rhamnosus cells with
MBF-specific antiserum. Immunogold transmission electron microscopy (TEM)
of L. rhamnosus GG, its inactivated EPS knockout mutant (CMPG5351), and L.
rhamnosus LC705 was performed according to a published procedure (21), but
with minor modifications. Briefly, overnight-grown L. rhamnosus cells were re-
covered by centrifugation and the cell pellets were rinsed once with PBS and then
diluted (OD600 of 1.0) in the same buffer. Formvar-carbon-coated copper grids
were incubated for 1 h on droplets of the diluted L. rhamnosus cell suspensions,
rinsed several times with 0.02 M glycine in PBS, and immersed in a blocking
solution of 1% BSA in PBS. The grids were then incubated for 1 h on droplets
of blocking solution containing anti-MBF serum (diluted 1:100), rinsed exten-
sively with 0.1% BSA in PBS to wash away unbound antibodies, and treated for
20 min with protein A conjugated to 10-nm-diameter gold particles (pAg) diluted
1:55 in blocking solution. Incubation of the grids with rabbit preimmune serum
was also included and served as the negative control. After rinsing four times
with PBS, each of the grids was fixed with 1% glutaraldehyde, rinsed eight times
with distilled water, and then negatively stained with 1.8% methylcellulose-0.4%
uranyl acetate. The grids were examined and the magnified images of L. rham-
nosus cells were obtained with a JEOL 1200 EX II transmission electron micro-
scope.
Statistical analysis. To account for the statistical significance of the mucus-
binding data for radiolabeled proteins (125I) or L. rhamnosus cells (3H), pairwise
comparisons were performed among the measured samples using Student’s t test.
Calculated P values of 0.05 or less were regarded as significant.
RESULTS AND DISCUSSION
Domain organization and primary structure comparison of
L. rhamnosus GG MBF protein. In previous work, the pre-
dicted 438-aa product of the LGG_02337 ORF in L. rhamno-
sus GG was identified as a potential cell wall-associated adhe-
sin (21) which we now call the mucus-binding factor (MBF)
protein. Here, in our present analysis of the MBF primary
structure, we determined the sequence for a 41-aa N-terminal
secretion signal by using the SignalP 3.0 prediction server (5)
(http://www.cbs.dtu.dk/services/SignalP/) (Fig. 1A). Moreover,
we manually identified a 37-aa C-terminal LPXTG-like an-
choring domain beginning with the LPNTN motif, followed by
a stretch of predominantly aliphatic amino acids, and ending
with a cluster of four positively charged residues (Fig. 1A).
Since the presence of both domains is an essential prerequisite
for sortase-catalyzed attachment of cell wall proteins, there is
little doubt that MBF is a substrate for sortase action, and thus
the processed 38-kDa protein is likely to be a cell wall-
anchored surface component. Given that the deduced amino
acid sequence for MBF protein contains four domain repeats
with homology to the Pfam-MucBP domain (Fig. 1A) (21), a
mucus-binding specificity for this LPXTG-like protein would
be a likely possibility. Interestingly, although some homology
has been reported to exist between the MucBP repeats and the
LAB-associated MUB domains (7), a primary structure align-
ment between the L. rhamnosus GG MBF protein and the
characteristic N-terminal region of the MUB domain (7) did
not produce any substantive sequence similarity (data not
shown). This seems to suggest that the MBF protein is different
from the MUB-containing proteins found in other lactobacilli.
Our results (data not shown) obtained from BlastP (http:
//blast.ncbi.nlm.nih.gov/Blast.cgi) searches against existing da-
tabases for proteins with sequence homology to the predicted
LGG_02337 ORF product revealed a high level of similarity
with proteins from taxonomically related species of L. rham-
nosus GG, including Lactobacillus paracasei, Lactobacillus
casei, and other L. rhamnosus strains. Moreover, moderate
amounts of similarity were observed with proteins primarily
from species of Listeria and, to a lesser extent, Enterococcus.
As shown in Fig. 1B, L. rhamnosus GG MBF protein and the
predicted homolog from the related L. rhamnosus LC705
strain are nearly identical (97.9%) to each other based on an
alignment of their amino acid sequences. Presently, the
LGG_02337 ORF in L. rhamnosus GG and the LC705_02328
ORF in L. rhamnosus LC705, each of which encode the MBF
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FIG. 1. Structural organization and amino acid sequence comparison of L. rhamnosus GG MBF protein. (A) A schematic illustration (not to
scale) of the domain organization for MBF protein is based on the deduced primary structure of the LGG_02337 ORF from L. rhamnosus GG.
Amino acid sequences for the N-terminal secretion signal (SS; gray box) and the C-terminal cell wall-anchoring domain (black box) beginning with
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protein, are annotated as an internalin J (InlJ) protein. How-
ever, despite displaying a reasonable amount of amino acid
sequence similarity with the four Pfam-MucBP repeats in the
lmo2821 ORF-encoded InlJ from the L. monocytogenes
EGD-e strain (18) (Fig. 1B), neither of the two L. rhamnosus
MBF ORFs encode a sequence for the internalin domain, an
N-terminal canonical structural feature consisting of 15 leu-
cine-rich repeat domains and one immunoglobulin (Ig)-like
interrepeat domain (6). Because the internalin domain is im-
plicated in the functionality of InlJ for mediating protein-
protein interactions during the infection process of L. mono-
cytogenes (10), it seems unlikely that MBF would have a similar
role, let alone be a member of the internalin protein family,
without the presence of this important functional domain in
the primary structure. Consequently, we suggest that the likely
primary role of MBF is for cell-mediated mucosal adhesion
and that the renaming of this LPXTG-like surface protein and
its gene (designated mbf) is appropriate.
L. rhamnosus GG MBF adheres to human intestinal mucus.
With the aim of providing physical evidence for the predicted
role of L. rhamnosus GG MBF as a mucus-binding adhesin, we
used purified recombinant MBF protein to assess its adherence
to human intestinal mucus by utilizing a microtiter plate-based
assay method developed previously for radioiodinated recom-
binant-produced pilin protein (21, 41). As demonstrated in the
mucus-binding profile shown in Fig. 2, recombinant MBF read-
ily adhered to intestinal mucus, although the amount of bind-
ing was about 2-fold less than that of the pilus-derived SpaC
protein (positive control). Expectedly, mucus binding for re-
combinant MBF and SpaC both exceeded the measured back-
ground (ovalbumin) level by 3- and 6-fold, respectively (Fig. 2).
Taken together, these results indicate that the ability of L.
rhamnosus GG MBF protein to bind to a mucosal surface is
fully consistent with a predicted function based on shared
primary structural homology with a known mucus adhesion
domain (see previous section).
Cell surface localization of MBF in L. rhamnosus GG. Im-
muno-electron microscopy. To determine the availability of the
MBF for cell-mediated adherence to the intestinal mucosa, we
used electron microscopic means for demonstrating its local-
ization as a cell wall-associated surface protein. However, de-
spite several attempts to show the presence of MBF proteins
on the cell surface of L. rhamnosus GG, we were unable to do
so convincingly with the WT strain by immunogold TEM using
antiserum directed against recombinant MBF protein. Our
TEM experiments revealed that MBF proteins are not easily
visible on the surface of L. rhamnosus GG cells, which was
apparent from the absence of observed gold particles (Fig. 3,
left). Nonetheless, given the high degree of sequence similarity
between MBF and its homolog from L. rhamnosus LC705 and
the likelihood for shared recognition of both proteins by L.
rhamnosus GG-derived MBF antiserum, we also examined the
L. rhamnosus LC705 strain to assess the functionality of the
MBF-specific antibodies. In contrast to L. rhamnosus GG or
when preimmune serum was used (data not shown), a high
number of gold particles was observed on the cell surface of L.
rhamnosus LC705 (Fig. 3, center). This not only indicated that
the MBF antiserum was functional but also provided visual
evidence for the surface localization of the MBF homolog in
this related L. rhamnosus strain. Since these two genetically
similar L. rhamnosus strains have been reported to differ in the
composition of their EPS layers (21, 23), we suspected that the
longer galactose-rich EPS repeating units found in L. rhamno-
sus GG, but not in L. rhamnosus LC705, might be the reason
for the observed difference in surface-localized MBF protein.
To test this possibility, we examined the uncovered surface of
an inactivated EPS knockout mutant of L. rhamnosus GG
(CMPG5351), which was used previously for establishing the
EPS layer as a potential shield of certain surface adhesins (23).
As shown in Fig. 3 (right panel), but not when using preim-
mune serum (data not shown), gold particles were visibly found
throughout the exposed surface of the EPS-deficient mutant
cell, providing suggestive evidence that MBF is a frequently
occurring surface component of L. rhamnosus GG.
the LPNTN motif (underlined) are depicted. Four regions in the primary structure with homology to the Pfam-MucBP domain repeats (MucBP;
white box) determined previously (21) are shown. (B) The multiple-amino-acid sequence alignment of L. rhamnosus GG MBF protein
(LGG_02337) with the MBF homolog from L. rhamnosus LC705 (LC705_02328 ORF) and the InlJ protein (lmo2821) from L. monocytogenes
EGD-e was performed using the MultAlin program (12) (http://multalin.toulouse.inra.fr/multalin/multalin.html) and formatted with the GeneDoc
program (27) (http://www.nrbsc.org/gfx/genedoc/index.html). The location of domains for 15 leucine-rich repeats (LRR), one Ig-like interrepeat
(Ig-like), and four Pfam-MucBP repeats (MucBP) in L. monocytogenes InlJ protein are shown, and the corresponding sequences are indicated
according to results described previously (34). Amino acids that are similar between the sequences for the L. rhamnosus GG and LC705 MBF
proteins (gray shading) and for the L. rhamnosus MBF proteins and the L. monocytogenes InlJ protein (black shading) are indicated.
FIG. 2. Adherence of L. rhamnosus GG MBF protein to human
intestinal mucus. The binding of 50-pmol amounts of 125I-labeled re-
combinant MBF protein and SpaC pilin to intestinal mucus was carried
out according to methods described in Materials and Methods. The
mucus adherence of 50 pmol radioiodinated ovalbumin represented
the background level of binding to mucus. All binding data represent
means 
 standard deviations for four to six measurements and the
differences between data (P  0.05) are considered significant. Addi-
tional details about the statistical analysis are described in Materials
and Methods.
VOL. 77, 2011 MUCUS-SPECIFIC SURFACE ADHESIN FROM L. RHAMNOSUS GG 4469
Immunoblotting. To confirm whether the L. rhamnosus GG
EPS layer is merely shielding the MBF epitopes and that com-
parable amounts of cell wall-bound MBF protein are produced
in L. rhamnosus GG and its EPS-deficient mutant derivative
(CMPG5351), mutanolysin-extracted cell wall proteins were
recovered from the WT and CMPG5351 strains and then ex-
amined for the presence of the MBF by immunoblotting with
anti-MBF serum. Cell wall proteins extracted from the L.
rhamnosus LC705 strain were included as a control. Mature or
fully processed monomeric MBF protein, which lacks the res-
idues of the N-terminal secretion signal and the C-terminal
region after the cleavage site in the LPXTG-like motif, and
recombinant-produced MBF could be expected to correspond
to predicted molecular weights of 38.2 and 39.8 kDa, respec-
tively. As shown in Fig. 4, protein bands of similar intensity
migrating just below the 40-kDa marker were detected for the
WT (lane 1) and EPS-deficient mutant (lane 2) L. rhamnosus
GG strains. As anticipated, similar-sized bands for the L.
rhamnosus LC705 strain (Fig. 4, lane 3) and purified recombi-
nant MBF protein (Fig. 4, lane 4) were also apparent on the
immunoblot. Unexpectedly, but in part due to an inexact frac-
tionation process, we also observed in these three strains ad-
ditional bands that likely represent MBF during the different
stages of protein processing and peptidoglycan anchoring. For
example, based on calculated sizes, we consider the band mi-
grating near the 50-kDa molecular size marker to be com-
pletely unprocessed MBF (46 kDa) that still contains the N-
and C-terminal signaling domains, whereas the faint diffuse
band found just above 40 kDa likely represents a partially
processed form of MBF (42 kDa) with an intact C-terminal
membrane-spanning domain.
We interpret the above findings by suggesting that the more
extended repeating units of carbohydrate associated with the
surrounding L. rhamnosus GG EPS layer, while initially allow-
ing the recognition of cell wall-bound MBF protein by anti-
body molecules to occur, might later form a physical obstruc-
tion that limits the accessibility of the immunoglobulin Fc
region to which the protein A-gold particles normally bind.
However, even so, our electron microscopic observations,
which revealed that MBF is scattered regularly throughout the
cell surface of both L. rhamnosus GG and LC705, corroborate
the predicted localization of this mucus adhesin as a cell wall-
anchored surface protein.
MBF-mediated adhesion of L. rhamnosus GG and LC705 to
intestinal mucus. To associate the physical availability of sur-
face-localized MBF proteins with cell-mediated mucosal adhe-
sion, we investigated if this cell wall-associated adhesin con-
tributes to the mucus-binding capacity of L. rhamnosus GG
and LC705 cells by performing antibody-mediated inhibition
experiments. Using SpaC pilin-specific antiserum to remove
the contribution of SpaCBA pili to mucosal adhesion in WT L.
rhamnosus GG, we were able to normalize the level of mucus
binding for L. rhamnosus GG and LC705, thereby allowing a
comparative assessment of MBF-mediated adherence between
these two strains. As shown in Fig. 5, WT L. rhamnosus GG
cells that were antibody untreated or pretreated with anti-
SpaC serum adhered to mucus much in the same way as was
reported previously (21, 41), such that SpaC-specific antibody
binding to SpaCBA pili blocked a large portion of L. rhamno-
sus GG-mediated adherence to mucus. Interestingly, when L.
rhamnosus GG (anti-SpaC serum-pretreated) and L. rhamno-
sus LC705 (non-SpaCBA-piliated) cells were treated with anti-
MBF serum, we found that the blocking action of the antibod-
ies had caused a relatively modest but statistically significant
reduction in mucus binding for each strain (Fig. 5). As these
results would imply, MBF proteins are responsible for medi-
ating a low level of mucosal adhesion in L. rhamnosus GG and
LC705 cells. Consequently, whereas MBF likely represents one
of the key mucus adhesins on the cell surface of the less
adhesive L. rhamnosus LC705 strain, this surface-localized
FIG. 3. Visualization of cell surface-localized MBF in L. rhamnosus GG. Immunogold labeling with anti-MBF serum and electron microscopy
analysis of the WT L. rhamnosus GG (GG; left) and LC705 (LC705; center) strains and the L. rhamnosus GG EPS-deficient welE mutant strain
(CMPG5351; right) were carried out as described in Materials and Methods. Arrows randomly identifying small dark dots indicate gold particle
labeling of MBF protein. The scale bar in each panel represents 0.2 m. An inset shows an enlarged view of cells from the panels of the L.
rhamnosus LC705 and L. rhamnosus GG welE mutant strains.
FIG. 4. Production of cell wall-associated MBF in L. rhamnosus
GG. Immunoblotting with anti-MBF serum of mutanolysin-extracted
cell wall proteins from normalized cultures of WT L. rhamnosus GG
(lane 1), the L. rhamnosus GG EPS knockout mutant (CMPG5351)
(lane 2), and WT L. rhamnosus LC705 (lane 3) was performed as
described in Materials and Methods. Purified recombinant MBF pro-
tein was included as a control (lane 4). The positions of unprocessed
(UP), partially processed (PP), and fully processed (FP) forms of MBF
protein are indicated on the right. Molecular weight markers and their
positions are indicated on the left.
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protein accounts for only a small fraction of the total mucus-
binding capacity in L. rhamnosus GG. For that reason, MBF
protein in SpaCBA-piliated L. rhamnosus GG, much like
MabA protein described previously (29), will likely have a
lesser adhesive role in establishing intimate interactions with
intestinal cells.
Intriguingly, even with its inherent EPS layer (23), which was
recently reported to wield a shielding effect against host pro-
tective factors (24), WT L. rhamnosus GG cells are apparently
able to mediate mucosal adhesion through the surface-local-
ized MBF. This might reflect the need for a closely interwoven
association between the L. rhamnosus GG cell surface and the
mucosal layer so that MBF proteins can bind optimally to
mucus-related molecules. In keeping with the binding strate-
gies of proposed adhesion models for various other piliated
Gram-negative and Gram-positive bacteria, we suggest that
only after the elongated mucus-specific pilus fibers make their
initial contact and attach L. rhamnosus GG cells to the mucosal
surface will MBF proteins be in such close proximity that their
binding also becomes a possibility. However, unlike Gram-
negative pili, which, due to the structural elasticity of their
subunit constituents, would be able to retract reversibly and
pull microbes closer to the host cells (17, 20, 26), pili from
Gram-positive bacteria appear to consist of inextensible pilin
subunits (2), making them more rigid and less apt to function
in a similar manner. Consequently, the SpaCBA pilus-medi-
ated binding in L. rhamnosus GG that brings LPXTG-like
surface adhesins (e.g., MBF and MabA) closer to the mucus
layer could expectedly be less dynamic and more arbitrary,
possibly relying on the “zipper-like” mechanistic explanation
of adhesion in piliated Gram-positive pathogens described pre-
viously (38). On the other hand, collectively, such a multiplicity
of adhesive interactions, including those of MBF, will undoubt-
edly allow L. rhamnosus GG to be better embedded in the
intestinal mucosa for what can be regarded as its increased
capacity of persistence in the intestine. In comparison, L.
rhamnosus LC705, by being demonstratively less adhesive to
mucosal surfaces (39), due likely to the absence of mucus-
binding pili, is more susceptible to the washout conditions of
the intestine and is a less persistent strain (21).
Conclusions. In our present study, we have now provided
evidence that an additional LPXTG-like protein, which we
renamed the mucus-binding factor, participates as another sur-
face-exposed component in the interaction between adherent
L. rhamnosus GG and the human intestinal mucosa. As an
allochthonous probiotic, L. rhamnosus GG is incapable of
forming a lifelong association with the intestinal host. How-
ever, based on our findings about MBF, together with those
from previous studies on the SpaCBA pilus (21) and MabA
(29), we put forward the idea that in L. rhamnosus GG, at least
these three different surface-localized components are part of
a protein-mediated adhesion mechanism, whose collective net-
work of mucus-binding interactions might contribute to the
increased capacity of this probiotic strain to survive as a com-
paratively more persistent and less stringent allochthonous in-
testinal inhabitant.
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